Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) entered the public markets through a de-SPAC merger with Soaring Eagle Acquisition Corp, a blank-check company sponsored by Eagle Equity Partners that filed its S-1 registration statement with the SEC on December 23, 2020. Soaring Eagle completed its IPO in early 2021 and subsequently announced a business combination with Ginkgo Bioworks, a synthetic biology platform company, in May 2021; the transaction closed in September 2021 with the combined entity retaining the Ginkgo Bioworks name and the ticker DNA on the NYSE. The deal represented one of the more prominent SPAC transactions in the biotechnology and industrial biology sector during that cycle. For complete filing history, sponsor details, and real-time deal tracking on DNA and hundreds of other SPAC transactions, sign up for full data access at SpacDesk.